Evidence map›Paper›PMID 18765736›Full record

ArticleInfection and immunity2008

Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity.

Douglas M Heithoff, Elena Y Enioutina, Diana Bareyan, Raymond A Daynes, Michael J Mahan

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 49 citations in OpenAlex.

  1. Frontiers in immunology · 2026
    Article
  2. Article
  3. Review
  4. Myeloid-derived suppressor cells and vaccination against pathogens.Frontiers in cellular and infection microbiology · 2022
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Gr1Journal of leukocyte biology · 2018
    Article
  12. Article
  13. Two NovelFrontiers in cellular and infection microbiology · 2017
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. A prophylactic vaccine for breast cancer?Breast cancer research : BCR · 2010
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Douglas M HeithoffDepartment of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA.
Elena Y Enioutina
Diana Bareyan
Raymond A Daynes
Michael J Mahan
University of Utah · USUniversity of California, Santa Barbara · US

Funding

Cross-Protective Vaccines vs. Emerging Infectious AgentsR01AI059242 · NIAID · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI MAHAN, MICHAEL J · 2005 to 2007
$1.4M
NIAID NIH HHS AI059242NIAID NIH HHS R01 AI059242
6 · The paper itself

Abstract

Immunity conferred by conventional vaccines is restricted to a narrow range of closely related strains, highlighting the unmet medical need for the development of vaccines that elicit protection against multiple pathogenic serotypes. Here we show that a Salmonella bivalent vaccine comprised of strains that lack and overproduce DNA adenine methylase (Dam) conferred cross-protective immunity to salmonella clinical isolates of human and animal origin. Protective immunity directly correlated with increased levels of cross-reactive opsonizing antibodies and memory T cells and a diminished expansion of myeloid-derived suppressor cells (MDSCs) that are responsible for the immune suppression linked to several conditions of host stress, including chronic microbial infections, traumatic insults, and many forms of cancer. Further, aged mice contained increased numbers of MDSCs and were more susceptible to Salmonella infection than young mice, suggesting a role for these cells in the immune declines associated with the natural aging process. These data suggest that interventions capable of reducing MDSC presence and activities may allow corresponding increases in B- and T-cell stimulation and benefit the ability of immunologically diverse populations to be effectively vaccinated as well as reducing the risk of susceptible individuals to infectious disease.

Indexed as

AgingAnimalsAntibodies, BacterialCross ReactionsHeLa CellsHumansImmunologic MemoryMiceMice, Inbred BALB CMice, Inbred C57BLMyeloid CellsSalmonellaSalmonella Infections, AnimalSalmonella VaccinesT-LymphocytesAntibodies, BacterialSalmonella Vaccines

Identifiers

PMID18765736
PMCPMC2573365
OpenAlexW2166902559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.